Shantha Biotechnics Overview
- Year Founded
-
1993
- Status
-
Acquired/Merged
- Employees
-
657
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
Shantha Biotechnics General Information
Description
Operator of a vaccine development and manufacturing company intended to serve across Hyderabad, India. The company specializes in the research, development, and manufacturing of Hepatitis B, Diphtheria, and Tetanus vaccines, thereby enabling public health initiatives in developing regions.
Contact Information
Website
www.shanthabiotech.comCorporate Office
- 3rd & 4th Floor, H.No5-10-173
- Fateh Maidan Road, Basheerbagh
- Hyderabad, Telangana 500004
- India
Corporate Office
- 3rd & 4th Floor, H.No5-10-173
- Fateh Maidan Road, Basheerbagh
- Hyderabad, Telangana 500004
- India
Shantha Biotechnics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Shantha Biotechnics Comparisons
Industry
Financing
Details
Shantha Biotechnics Competitors (23)
One of Shantha Biotechnics’s 23 competitors is Biocon, a Formerly PE-Backed company based in Bengaluru, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biocon | Formerly PE-Backed | Bengaluru, India | ||||
| Cipla | Corporation | Mumbai, India | ||||
| Torrent Pharmaceuticals | Corporation | Ahmedabad, India | ||||
| Glenmark Pharmaceuticals | Corporation | Mumbai, India | ||||
| Strides Pharma Science | Formerly VC-backed | Bangalore, India |
Shantha Biotechnics Patents
Shantha Biotechnics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2015128788-A1 | Purification of papillomavirus l2 protein | Inactive | 27-Feb-2014 | ||
| WO-2015068101-A1 | Papillomavirus vaccine formulations | Inactive | 06-Nov-2013 | ||
| AU-2014270076-A1 | Purification of polysaccharide protein conjugates | Inactive | 20-May-2013 | ||
| CA-2910119-A1 | Purification of polysaccharide protein conjugates | Inactive | 20-May-2013 | ||
| EP-2999709-A1 | Purification of polysaccharide protein conjugates | Inactive | 20-May-2013 | A61K39/102 |
Shantha Biotechnics Signals
Shantha Biotechnics Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Shantha Biotechnics FAQs
-
When was Shantha Biotechnics founded?
Shantha Biotechnics was founded in 1993.
-
Where is Shantha Biotechnics headquartered?
Shantha Biotechnics is headquartered in Hyderabad, India.
-
What is the size of Shantha Biotechnics?
Shantha Biotechnics has 657 total employees.
-
What industry is Shantha Biotechnics in?
Shantha Biotechnics’s primary industry is Drug Discovery.
-
Is Shantha Biotechnics a private or public company?
Shantha Biotechnics is a Private company.
-
What is Shantha Biotechnics’s current revenue?
The current revenue for Shantha Biotechnics is .
-
How much funding has Shantha Biotechnics raised over time?
Shantha Biotechnics has raised $208M.
-
Who are Shantha Biotechnics’s investors?
Phoenix Family Office Advisers, Rajit Malhotra, Sanofi, Shantha Biologics, and Valpro Capital are 5 of 6 investors who have invested in Shantha Biotechnics.
-
Who are Shantha Biotechnics’s competitors?
Biocon, Cipla, Torrent Pharmaceuticals, Glenmark Pharmaceuticals, and Strides Pharma Science are some of the 23 competitors of Shantha Biotechnics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process